Our top pick for
Palomar Holdings, Inc is an insurance-property & casualty business based in the US. Palomar shares (PLMR) are listed on the NASDAQ and all prices are listed in US Dollars. Palomar employs 77 staff and has a trailing 12-month revenue of around USD$160.8 million.
|52-week range||USD$39.21 - USD$121.87|
|50-day moving average||USD$101.1656|
|200-day moving average||USD$94.2128|
|Wall St. target price||USD$108.14|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||USD$0.754|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Valuing Palomar stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Palomar's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Palomar's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 117x. In other words, Palomar shares trade at around 117x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Palomar's EBITDA (earnings before interest, taxes, depreciation and amortisation) is USD$23.3 million.
The EBITDA is a measure of a Palomar's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||USD$160.8 million|
|Operating margin TTM||14.32%|
|Gross profit TTM||USD$24.4 million|
|Return on assets TTM||2.68%|
|Return on equity TTM||6.66%|
|Market capitalisation||USD$2.4 billion|
TTM: trailing 12 months
There are currently 1.2 million Palomar shares held short by investors – that's known as Palomar's "short interest". This figure is 1.9% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting Palomar shares can be evaluated.
Palomar's "short interest ratio" (SIR) is the quantity of Palomar shares currently shorted divided by the average quantity of Palomar shares traded daily (recently around 195378.36065574). Palomar's SIR currently stands at 6.1. In other words for every 100,000 Palomar shares traded daily on the market, roughly 6100 shares are currently held short.
However Palomar's short interest can also be evaluated against the total number of Palomar shares, or, against the total number of tradable Palomar shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Palomar's short interest could be expressed as 0.05% of the outstanding shares (for every 100,000 Palomar shares in existence, roughly 50 shares are currently held short) or 0.0585% of the tradable shares (for every 100,000 tradable Palomar shares, roughly 59 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against Palomar.
Find out more about how you can short Palomar stock.
We're not expecting Palomar to pay a dividend over the next 12 months.
Palomar Holdings, Inc. provides specialty property insurance. It offers personal and commercial specialty property insurance products, including residential and commercial earthquake, specialty homeowners, commercial all-risk, Hawaii hurricane, residential flood, inland marine, assumed reinsurance, and real estate investor. The company was formerly known as GC Palomar Holdings. Palomar Holdings, Inc. was incorporated in 2013 and is headquartered in La Jolla, California.
Everything we know about the Toast Inc IPO, plus information on how to buy in.
Everything we know about the Cyxtera IPO, plus information on how to buy in.
Everything we know about the ATI Physical Therapy IPO, plus information on how to buy in.
Everything we know about the Sportradar IPO, plus information on how to buy in.
Everything we know about the Longboard Pharmaceuticals Inc IPO, plus information on how to buy in.
Everything we know about the Prometheus Biosciences Inc IPO, plus information on how to buy in.
Everything we know about the Olo Inc IPO, plus information on how to buy in.
Everything we know about the China Eco-Materials Group Co Limited IPO, plus information on how to buy in.
Everything we know about the Gain Therapeutics Inc IPO, plus information on how to buy in.
Everything we know about the Karat Packaging Inc IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.